We connect pioneering healthcare innovators with the right investors, funding structures, and strategic partners to accelerate market entry and scale globally.
Generic investment advisors don't understand NHS procurement, clinical evidence requirements, or healthcare regulatory pathways. We do.
We help pre-revenue innovators structure compelling investment propositions — from proof-of-concept through to Series A. Our team bridges the gap between clinical insight and investor language.
For commercially validated innovations ready to scale, we connect founders with growth-stage investors, NHS procurement frameworks, and international distribution partners.
We facilitate joint ventures, licensing arrangements, and corporate partnerships that accelerate deployment across NHS trusts, private healthcare groups, and global markets.
Our M&A advisory supports both buy-side and sell-side transactions in digital health, medtech, and healthcare services — with sector expertise that generic advisors lack.
A structured, proven methodology that takes the uncertainty out of raising capital for healthcare innovation.
We conduct a deep-dive into your innovation, market position, IP landscape, and financial projections to determine investment readiness.
We co-create an investor-ready narrative — pitch decks, financial models, health economic evidence, and clinical validation summaries.
Using our proprietary network and the IDC platform, we match your innovation to the most aligned investor profiles and funding vehicles.
We support term sheet negotiation, due diligence facilitation, and legal coordination through to close and post-investment management.
We've spent years building relationships with investors who genuinely understand healthcare. Our curated network means your innovation is matched to aligned, knowledgeable capital partners — reducing friction and accelerating deals.
From early-stage NHS-backed innovation funds to international strategic investors seeking UK healthcare entry, we bring the full spectrum to the table.
Talk to Our TeamInvestment is only part of the journey. We ensure your capital goes further with specialist NHS go-to-market strategy and international market entry support.
Navigating NHS procurement is a specialism in itself. We design bespoke GTM strategies that align your innovation with NHS priorities, ICB budgets, QIPP targets, and commissioner decision-making frameworks.
For innovations with global potential, we provide market entry strategy across the US, EU, Middle East, and Asia-Pacific — with regulatory, commercial, and cultural intelligence built in.
We only work in healthcare. That depth of focus means we understand what investors need and what regulators require — without the learning curve.
Our deal flow is relationship-driven. We don't blast your deck to generic lists — we make targeted, warm introductions to aligned capital.
We build investment cases grounded in real-world clinical evidence, health economics, and proven procurement success — not just financial projections.
From the first pitch to post-close integration, we stay involved. Our success is tied to yours, not just the initial mandate.
With partners in the US, EU, Middle East, and Asia-Pacific, we open doors beyond the UK for innovations ready to scale internationally.
Every engagement starts with our Maturity & Readiness Engine — giving you and investors a validated, objective view of your innovation's commercial readiness.
Start with our free Maturity & Readiness Assessment to understand where you stand — then let's build your investment strategy together.
Tell us about your project and we'll adapt our approach to fit.